News
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSNKY) announced Wednesday that Enhertu, their jointly developed antibody-drug conjugate, reached the main goal in a Phase 3 trial in certain ...
For her look, Kim’s go-to hair stylist Chris Appleton used Color Wow’s cult favourite Dream Coat Supernatural Spray to prep her hair for the event, which not only kept it sleek and shiny ...
Celebrities have access to the best glam squads in the world -- but sometimes even they can’t prevent a bad spray tan. While stars usually want a little extra glow while hitting the red carpet ...
Cole, from Runcorn, Cheshire, said: "It looked like the same kind of thing I normally see whizzing around but it was much lower, it was brighter, and you could almost see a ring of light spinning ...
Astrazeneca's boss has warned Europe is falling behind as it steps up investment in the United States. Pascal Soriot said innovation in pharmaceuticals ‘has mostly been funded by the US’ as he ...
AstraZeneca is a posterchild of the UK stock market as Britain's largest listed company. So it's telling that it too is warning that there is a risk a trade war could damage both its bottom line ...
In January, AstraZeneca announced an $820 million investment in Canada. This latest commitment creates more than 700 highly skilled jobs across all areas of the business. This news follows a $500M ...
London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs ...
AstraZeneca Plc’s Chief Executive Officer Pascal Soriot warned that trade tariffs are not the best way to manage pharmaceuticals and that drugmakers are calling for no additional US levies on ...
AstraZeneca has come up short in another phase 3 trial of the AKT inhibitor Truqap, raising more questions about the blockbuster potential of the first-in-class cancer treatment. Alongside its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results